Chinese medical journal
First-line atezolizumab monotherapy vs. single-agent chemotherapy in patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum-based therapy: Analysis of the IPSOS Asian subpopulation.
Baohui Han, Solange Peters, Anh Tuan Le, Dingzhi Huang, Gang Wu, Lejie Cao, Cam Phuong Pham, Jun Zhao, Kai Wang, Nong Yang, Hua Zhong, Youyou Hu, Stefanie Morris, Verena Lam, Vilma Graupner
Published: 202510.1097/CM9.0000000000003796
Abstract
BACKGROUND: Lung cancer remains a significant medical problem in Asia, and improved treatments are needed for patients diagnosed with non-small cell lung cancer (NSCLC), who are frail with poor performance status or substantial comorbidities. This st…
Preview only. Read the full abstract at the source